journal article·2026-03Open access

EGR Proteins Mediate Interferon‐Independent Anti‐HSV‐1 Responses Through Viral and Host Targets

Shuaishuai Wang, Fujun Hou, Xunuo Jin, Yuhang Xiang, Dongli Pan

Advanced Science· Volume 13· Issue 13

Abstract

ABSTRACT Quick responses to viral infections, which are essential for controlling viral diseases, are typically mediated by interferons. Herpes simplex virus 1 (HSV‐1) switches between lytic and latent infections in neurons. Here we show that host early growth response ( Egr ) genes (including Egr1 ‐ Egr4 ), which are not interferon‐stimulated genes, are generally upregulated in HSV‐1‐infected neuronal cells and acutely infected mouse ganglia. Surprisingly, Egr1 upregulation is independent of previously reported pathways upstream of Egr1 expression but dependent on viral protein ICP0. EGR1, in turn, represses HSV‐1 replication in neuronal cells. Recombinant HSV‐1 expressing EGR1 exhibits reduced replication in mouse ganglia and brainstems in vivo. Mechanistically, EGR1 binds to sites within the viral latency‐associated transcript ( LAT ) gene promoter to increase LAT expression, which is known to favor repression of viral lytic genes. Concurrently, EGR1 can stimulate the expression of host immune proteins IRF7 and ISG15, and IRF7 is required for the anti‐HSV‐1 function of EGR1. Interestingly, both EGR1 and IRF7 suppress HSV‐1 replication independent of interferons. Furthermore, EGR2, EGR3, and EGR4 can enhance LAT and IRF7 expression too. In summary, EGR proteins are upregulated during HSV‐1 infection and mediate interferon‐independent antiviral responses through both viral and host targets.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Herpesvirus Infections and Treatments · interferon and immune responses · Viral Infections and Immunology Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases National Clinical Research Center for Infectious Diseases Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China

Department of Microbiology Zhejiang University School of Medicine Hangzhou China

Department of Ophthalmology Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · State Key Laboratory for Diagnosis and Treatment of Infectious Diseases

References (62)

Show source-provided references
1. Knipe D. M. · 2021 · 235
2. 10.1128/MMBR.00099-2010.1128/MMBR.00099-20 ↗
3. 10.1016/j.virol.2024.11032410.1016/j.virol.2024.110324 ↗
4. 10.1128/jvi.00303-2510.1128/jvi.00303-25 ↗
5. 10.1128/jvi.01352-2210.1128/jvi.01352-22 ↗
6. 10.1038/nature0710310.1038/nature07103 ↗
7. 10.1128/JVI.02725-0910.1128/JVI.02725-09 ↗
8. 10.1128/JVI.02001-1610.1128/JVI.02001-16 ↗
9. 10.3390/v1406121510.3390/v14061215 ↗
10. 10.1016/j.chom.2014.03.00410.1016/j.chom.2014.03.004 ↗
11. 10.1038/s41564-020-00860-110.1038/s41564-020-00860-1 ↗
12. 10.1038/s41467-024-46057-610.1038/s41467-024-46057-6 ↗
13. 10.15252/embr.20215254710.15252/embr.202152547 ↗
14. 10.1016/j.celrep.2017.01.01710.1016/j.celrep.2017.01.017 ↗
15. 10.1128/jvi.71.8.5878-5884.199710.1128/jvi.71.8.5878-5884.1997 ↗
16. 10.1128/JVI.71.8.5885-5893.199710.1128/JVI.71.8.5885-5893.1997 ↗
17. 10.1371/journal.ppat.100553910.1371/journal.ppat.1005539 ↗
18. 10.1128/JVI.72.6.5067-5075.199810.1128/JVI.72.6.5067-5075.1998 ↗
19. 10.1128/JVI.00712-0910.1128/JVI.00712-09 ↗
20. 10.1073/pnas.050585010210.1073/pnas.0505850102 ↗
21. 10.1126/science.287.5457.150010.1126/science.287.5457.1500 ↗
22. 10.1128/JVI.75.14.6660-6675.200110.1128/JVI.75.14.6660-6675.2001 ↗
23. Activation and Function of Immediate‐early Genes in the Nervous System
24. 10.1016/S0197-0186(96)00136-210.1016/S0197-0186(96)00136-2 ↗
25. 10.1128/MCB.15.4.227510.1128/MCB.15.4.2275 ↗
26. 10.3389/fnbeh.2017.0003510.3389/fnbeh.2017.00035 ↗
27. 10.3389/fmicb.2022.102022010.3389/fmicb.2022.1020220 ↗
28. 10.18632/oncotarget.2064810.18632/oncotarget.20648 ↗
29. 10.1016/j.febslet.2007.01.02010.1016/j.febslet.2007.01.020 ↗
30. 10.1371/journal.ppat.100803710.1371/journal.ppat.1008037 ↗
31. 10.1371/journal.ppat.100785410.1371/journal.ppat.1007854 ↗
32. 10.1186/1743-422X-8-26210.1186/1743-422X-8-262 ↗
33. Suppression of Transcription Factor Early Growth Response 1 Reduces herpes Simplex Virus Lethality in Mice
34. 10.1128/JVI.00505-1210.1128/JVI.00505-12 ↗
35. Induction of Transcription Factor Early Growth Response Protein 1 during HSV‐1 Infection Promotes Viral Replication in Corneal Cells
36. 10.3109/1355028970901829610.3109/13550289709018296 ↗
37. 10.1038/cr.2007.4410.1038/cr.2007.44 ↗
38. 10.1007/s11033-021-06305-010.1007/s11033-021-06305-0 ↗
39. 10.1016/j.cell.2015.05.03210.1016/j.cell.2015.05.032 ↗
40. 10.1016/j.virol.2019.10.01610.1016/j.virol.2019.10.016 ↗
41. 10.1016/j.chom.2010.09.00710.1016/j.chom.2010.09.007 ↗
42. 10.1074/jbc.M80058320010.1074/jbc.M800583200 ↗
43. 10.1101/gad.250746.11410.1101/gad.250746.114 ↗
44. 10.1128/JVI.06995-1110.1128/JVI.06995-11 ↗
45. 10.1128/JVI.01377-0910.1128/JVI.01377-09 ↗
46. 10.1073/pnas.060703810410.1073/pnas.0607038104 ↗
47. 10.1007/s13365-018-0666-910.1007/s13365-018-0666-9 ↗
48. 10.1038/nature0346410.1038/nature03464 ↗
49. 10.1038/s41467-025-55928-510.1038/s41467-025-55928-5 ↗
50. 10.1038/s41586-021-04054-510.1038/s41586-021-04054-5 ↗
51. 10.1016/j.celrep.2014.11.01910.1016/j.celrep.2014.11.019 ↗
52. 10.1128/jvi.00920-2210.1128/jvi.00920-22 ↗
53. 10.1371/journal.pone.004422710.1371/journal.pone.0044227 ↗
54. 10.1074/jbc.M110.16593610.1074/jbc.M110.165936 ↗
55. 10.1016/j.celrep.2020.10834510.1016/j.celrep.2020.108345 ↗
56. 10.1016/j.virol.2021.01.01610.1016/j.virol.2021.01.016 ↗
57. 10.1371/journal.ppat.101030110.1371/journal.ppat.1010301 ↗
58. 10.2144/00011209610.2144/000112096 ↗
59. 10.1128/mBio.02856-1810.1128/mBio.02856-18 ↗
60. 10.1038/nprot.2007.13210.1038/nprot.2007.132 ↗
61. 10.3389/fmicb.2022.85647110.3389/fmicb.2022.856471 ↗
62. 10.1128/JVI.02476-1310.1128/JVI.02476-13 ↗